4//SEC Filing
Neos Therapeutics, Inc. 4
Accession 0001104659-17-029070
CIK 0001467652operating
Filed
May 1, 8:00 PM ET
Accepted
May 2, 9:09 PM ET
Size
7.0 KB
Accession
0001104659-17-029070
Insider Transaction Report
Form 4
McDonnell Thomas P
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-05-01+45,000→ 45,000 totalExercise: $7.00Exp: 2027-05-01→ Common Stock (45,000 underlying) - Award
Common Stock
2017-05-01+15,000→ 18,000 total
Footnotes (2)
- [F1]Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in four equal, annual installments beginning on May 1, 2018.
- [F2]This stock option will vest in four equal, annual installments beginning on May 1, 2018.
Documents
Issuer
Neos Therapeutics, Inc.
CIK 0001467652
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001467652
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 9:09 PM ET
- Size
- 7.0 KB